Literature DB >> 33216537

Rational Ligand Design Enables pH Control over Aqueous Iron Magnetostructural Dynamics and Relaxometric Properties.

Huan Wang, Alison Wong, Luke C Lewis1, Genevieve R Nemeth, Veronica Clavijo Jordan, Jeffrey W Bacon2, Peter Caravan, Hannah S Shafaat1, Eric M Gale.   

Abstract

Complexes of Fe3+ engage in rich aqueous solution speciation chemistry in which discrete molecules can react with solvent water to form multinuclear μ-oxo and μ-hydroxide bridged species. Here we demonstrate how pH- and concentration-dependent equilibration between monomeric and μ-oxo-bridged dimeric Fe3+ complexes can be controlled through judicious ligand design. We purposed this chemistry to develop a first-in-class Fe3+-based MR imaging probe, Fe-PyCy2AI, that undergoes relaxivity change via pH-mediated control of monomer vs dimer speciation. The monomeric complex exists in a S = 5/2 configuration capable of inducing efficient T1-relaxation, whereas the antiferromagnetically coupled dimeric complex is a much weaker relaxation agent. The mechanisms underpinning the pH dependence on relaxivity were interrogated by using a combination of pH potentiometry, 1H and 17O relaxometry, electronic absorption spectroscopy, bulk magnetic susceptibility, electron paramagnetic resonance spectroscopy, and X-ray crystallography measurements. Taken together, the data demonstrate that PyCy2AI forms a ternary complex with high-spin Fe3+ and a rapidly exchanging water coligand, [Fe(PyCy2AI)(H2O)]+ (ML), which can deprotonate to form the high-spin complex [Fe(PyCy2AI)(OH)] (ML(OH)). Under titration conditions of 7 mM Fe complex, water coligand deprotonation occurs with an apparent pKa 6.46. Complex ML(OH) dimerizes to form the antiferromagnetically coupled dimeric complex [(Fe(PyCy2AI))2O] ((ML)2O) with an association constant (Ka) of 5.3 ± 2.2 mM-1. The relaxivity of the monomeric complexes are between 7- and 18-fold greater than the antiferromagnetically coupled dimer at applied field strengths ranging between 1.4 and 11.7 T. ML(OH) and (ML)2O interconvert rapidly within the pH 6.0-7.4 range that is relevant to human pathophysiology, resulting in substantial observed relaxivity change. Controlling Fe3+ μ-oxo bridging interactions through rational ligand design and in response to local chemical environment offers a robust mechanism for biochemically responsive MR signal modulation.

Entities:  

Year:  2020        PMID: 33216537     DOI: 10.1021/acs.inorgchem.0c02923

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  5 in total

1.  Enzyme Control Over Ferric Iron Magnetostructural Properties.

Authors:  Huan Wang; Michael B Cleary; Luke C Lewis; Jeffrey W Bacon; Peter Caravan; Hannah S Shafaat; Eric M Gale
Journal:  Angew Chem Int Ed Engl       Date:  2021-12-02       Impact factor: 15.336

2.  Comparison of phosphonate, hydroxypropyl and carboxylate pendants in Fe(III) macrocyclic complexes as MRI contrast agents.

Authors:  Elizabeth A Kras; Samira M Abozeid; Waldine Eduardo; Joseph A Spernyak; Janet R Morrow
Journal:  J Inorg Biochem       Date:  2021-08-28       Impact factor: 4.336

3.  Metal-Organic Polyhedron with Four Fe(III) Centers Producing Enhanced T1 Magnetic Resonance Imaging Contrast in Tumors.

Authors:  Gregory E Sokolow; Matthew R Crawley; Daniel R Morphet; Didar Asik; Joseph A Spernyak; A J Robert McGray; Timothy R Cook; Janet R Morrow
Journal:  Inorg Chem       Date:  2022-01-24       Impact factor: 5.436

4.  Liposomal Fe(III) Macrocyclic Complexes with Hydroxypropyl Pendants as MRI Probes.

Authors:  Samira M Abozeid; Md Saiful I Chowdhury; Didar Asik; Joseph A Spernyak; Janet R Morrow
Journal:  ACS Appl Bio Mater       Date:  2021-10-15

Review 5.  Bioimaging agents based on redox-active transition metal complexes.

Authors:  Shan-Shan Xue; Yingbo Pan; Wei Pan; Shujie Liu; Na Li; Bo Tang
Journal:  Chem Sci       Date:  2022-07-27       Impact factor: 9.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.